Navigation Links
Komen for the Cure Launches 'Presidential' Campaign
Date:9/26/2007

Outreach Efforts Will Raise Breast Cancer Awareness in New Hampshire and

Seek Presidential Candidates' Support for Stronger National Policies

MANCHESTER, N.H., Sept. 26 /PRNewswire-USNewswire/ -- Susan G. Komen for the Cure has announced the launch of a public policy campaign aimed at educating and mobilizing New Hampshire voters and challenging the 2008 Presidential candidates to make breast cancer a priority -- in their platforms, and for the country.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

Komen for the Cure has produced a radio message which will be distributed to stations across New Hampshire to help raise the profile of breast cancer in the state. The organization is also mailing postcards to over 50,000 registered voters, encouraging them to ask the candidates where they stand on key breast cancer priorities and to "vote for the cure."

"New Hampshire has been hard hit by breast cancer and low-income women and women of color have been hit the hardest. We need to close the gaps in research, policy and access to quality care that make breast cancer deadlier for some women," said Komen President and CEO Hala Moddelmog. "Asking all the Presidential candidates to make the fight against breast cancer a priority is essential to achieving a better national breast cancer policy."

On November 6th, Komen is inviting all spouses of Presidential candidates to participate in a discussion with elected officials, doctors, scientific researchers, advocates and breast cancer survivors about the importance of health care and breast cancer research. The Leadership Forum on Breast Cancer will be held at Dartmouth-Hitchcock's Norris Cotton Cancer Center.

The New Hampshire effort is part of Komen's I Vote for the Cure(TM) campaign (http://www.ivoteforthecure.org) which ch
'/>"/>

SOURCE Susan G. Komen for the Cure
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
8. Pfizer Launches Viagra For Lung Disease In UK
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...exas Health Science Center at Houston will launch ...s (TEXAS), to promote geriatrics training for phys... the Donald W. Reynolds Foundation and $1.25 milli...ch geriatric medicine principles to everyone from ...icians. With the reach of Lyndon B. Johnson Genera...
(Date:11/21/2008)...ll/ -- The Providence Service,Corporation (Nasdaq...he Company,s,Chief Operating Officer, has been ap... Norris, appointment fills the vacancy left by the... returns the board to six members. Mr.,Norris wi... Mr. Norris, age 41, has been with Providence si...
(Date:11/21/2008)...nst Lennox-Gastaut syndrome , , FRIDAY, ...el (rufinamide) has been approved as a supplementa...Lennox-Gastaut syndrome, the U.S. Food and Drug Ad...as based on results of a four-month clinical trial...patients who took a placebo, those who took the dr...
(Date:11/21/2008)...ewswire/ -- New research at West Virginia Univers...bacco product aimed at young adults is catching on... Camel Snus - touted as a socially acceptable way ...levels of nicotine. , , "Camel Snus contain...aid Bruce Adkins of the state Division of Tobacco ...
Breaking Medicine News(10 mins):Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3
...e ‘Mini’ Way to Stop Atrial Fibrillation in its Tr...ds of Americans with intermittent atrial fibrillat... of the Cox-Maze procedure //that involves scarrin...es sent by the brain to travel correctly. Richard ...
...bert Watson, a graduate student in the Section of ...f Medicine has found the uncommon path taken by Ca...s cells. Records show that, "campylobacteriosis,"...rhea worldwide, strikes 2.4 million Americans a ye...
...ala Lumpur: Five Malaysian states have registered ...first week of the year, with authorities fearing t...ead due to the rainy season, reports said Wednesda...an registered the highest jump, from 18 cases in t...
...new study finds that obesity increases the risk of...ot increase the overall risk a man will be diagnos... CANCER, a peer-reviewed journal of the American C... higher body mass index (BMI) and weight gain in a...
Other Medicine News:Health News:The Uncommon Pathway of Campylobacter Jejuni 2Health News:Mosquito-borne Dengue Disease on the Rise in Five Malaysian States 2Health News:Excess Weight and Adult Weight Gain Increase Risk of Prostate Cancer Death 2
(Date:11/20/2008)...E RESULTS OF FIRST PHASE III TRIAL SHOW SIGNIFICAN...MENT IN DAILY FUNCTION, IN, ...f., and BRUSSELS, Belgium, Nov. 20 /PRNewswire-Fir...JAZZ ) and UCB (Euronext Brussels: UCB),announced...the first of two,Phase III pivotal clinical trial...
(Date:11/20/2008).... 20 Bionovo, Inc.,(Nas...esults from the Phase 1B,clinical trial of their ...,cancer, BZL101, at the Society for Integrative O...ta, Georgia. The Company,s oral presentation was ...esented as a part of the Best of the,SIO Session ...
(Date:11/20/2008)...wswire/ -- Clinical data from a prospective,regis...ymposium shows DVT,treatment with the Trellis(R) ... Inc. (Santa Clara, CA) successfully breaks up the... , This technique, called isolated pharmaco... quickly and safely than current catheter-directed...
(Date:11/19/2008)... Posit Science Corporation,researc... for Neuroscience,Annual Conference in Washington... may benefit Baby Boomers. The computerized brain... adaptive exercises that target auditory and,lang... generalized,improvements in cognition by improvi...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Brookdale to Present at Citi Small 26 Mid Cap Conference on March 17 13982 1GeneNews receives ISO 13485 accreditation 3846 1GeneNews receives ISO 13485 accreditation 3846 2Mentice AB Announces Leadership Changes Within Its Worldwide Operations 3844 1Mentice AB Announces Leadership Changes Within Its Worldwide Operations 3844 2Peregrine Pharmaceuticals Announces Positive Data From Cotara 28R 29 Brain Cancer Trials 13980 1Peregrine Pharmaceuticals Announces Positive Data From Cotara 28R 29 Brain Cancer Trials 13980 2Peregrine Pharmaceuticals Announces Positive Data From Cotara 28R 29 Brain Cancer Trials 13980 3Peregrine Pharmaceuticals Announces Positive Data From Cotara 28R 29 Brain Cancer Trials 13980 4Peregrine Pharmaceuticals Announces Positive Data From Cotara 28R 29 Brain Cancer Trials 13980 5Peregrine Pharmaceuticals Announces Positive Data From Cotara 28R 29 Brain Cancer Trials 13980 6
...s from placebo,controlled phase IIa study in patie...IEREN (Zurich), Switzerland, May 15, 2007 - Cytos ...e results from a multi-centre,and placebo-controll...CYT003-QbG10, an immunotherapeutic product candida...dy included 40 patients,suffering from mild to mod...
...Weeks Reinforces,Benefits of Using REVLIMID with L...if., May 15, 2007 /PRNewswire/ -- The,Internationa...nd,providing education, advocacy and support for m...ans - today said that for the,second time in four ...R) has demonstrated positive findings and therefor...
Other Medicine Technology:Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 2Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 3Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 4Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 5Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 6Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 7The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 2The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 3
Kaye Skin Hook, Single Prong
Designated most popular model or size.
Large deep curve.
Needle tip electrode, davol advantage electrosurgical attachments, 33cm (with extendible outer sheath), non-sterile. These products are supplied non-sterile and must be sterilized before use. Reusabl
Medicine Products: